Font Size: a A A
Keyword [FLT3-ITD+]
Result: 61 - 80 | Page: 4 of 5
61. Comparison Of The Efficacy Of Sorafenib Maintenance Therapy And Prophylactic Donor Lymphocyte Infusion In Preventing Recurrence Of FLT3-ITD Positive Acute Myeloid Leukemia After
62. Efficacy Of Sorafenib In The Treatment Of FLT3-ITD Positive Acute Myeloid Leukemia:a Meta-analysis
63. Identification And Development Of 1,4-diaryl-1,2,3-triazolo-based Ureas As Novel FLT3 Inhibitors
64. Molecular mechanisms of FLT3-ITD-induced leukemogenesis
65. Combinatorial Inhibition Of Notch And FLT3 Produces Synergistic Cytotoxic Effects In FLT3-ITD+Acute Myeloid Leukemia
66. Synergistic Mechanism Of Gilteritinib Combined With ATO On FLT3-ITD Mutant Cells
67. Acute Myeloid Leukemia Exosomes Induce CD8~+T Cell Apoptosis And AMLCD8~+T Cell TCR Characteristics
68. Immunophenotype And Clinical Characteristics Of Acute Myeloid Leukemia With Positive FLT3-ITD
69. Clinical Features And Prognostic Analysis Of FLT3-ITD Positive Patients In Acute Myeloid Leukemia With RUNX1-RUNX1T1 Chromosomal Translocations
70. Efficacy And Safety Evaluation Of Sorafenib In The Treatment Of FLT3-ITD Positive Acute Myeloidleukemia
71. Wu-5,a Novel USP10 Inhibitor,Synergistically Enhances Crenolanib-induced Cell Death In FLT3-ITD-positive AML Cells Via Inhibiting AMPK And FLT3 Pathways
72. Clinical Characteristics And Prognosis Of Acute Myeloid Leukemia Patients With NPM1 Mutation
73. The Clinical Features、Prognosis、Bioinformatics Analysis Of NPM1/FLT3-ITD/DNMT3A Triple-mutated Acute Myeloid Leukemia
74. Neogambogic Acid(NGA)induces Apoptosis In FLT3-ITD(+)AML Through Degrading FLT3 And Increasing Intracellular Reactive Oxygen Species Level
75. Pattern And Prognostic Significance Of FLT3 Gene Mutation In Chinese Adult Patients With Hematologic Malignancies
76. CRISPR/Cas9-mediated Knockout Of MiR-155 On TKI Sensitivity And Glucose Metabolism In FLT3-ITD+ Acute Myeloid Leukemia
77. Effect Of Post-transplantation Sorafenib Maintenance In FLT3-ITD Acute Myeloid Leukemia With Different Genetic Abnormalities And Its Mechanism
78. The Role And Mechanism Of IGF2BP2 And YAP1 In The Pathogenesis And Drug Resistance Of Acute Leukemia
79. The Anti-leukemia Effect And Its Mechanisms Of Shikonin Against Acute Myeloid Leukemia With FLT3-ITD Mutation
80. Effects Of Paclitaxel Alone Or In Combination With Sorafenib On The FLT3-ITD Mutation AML Cell Lines
  <<First  <Prev  Next>  Last>>  Jump to